Back
Ascendis Pharma AS Quote, Financials, Valuation and Earnings
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
30
ASND
Ascendis Pharma AS
Last Price:
126.56
Seasonality Move:
15.69%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.Ascendis Pharma AS Price Quote
$126.56
+0.05 (+1.83%)
(Updated: November 16, 2024 at 5:07 AM ET)
Ascendis Pharma AS Key Stats
Sell
30
Ascendis Pharma AS (ASND)
is a Sell
Day range:
$118.05 - $133.00
52-week range:
$90.13 - $161.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
20.91
P/B ratio:
0%
Volume:
1.4M
Avg. volume:
445.5K
1-year change:
36.08%
Market cap:
$7.6B
Revenue:
$288.8M
EPS:
$-9.35
How Much Does Ascendis Pharma AS Make?
-
How Much Are Ascendis Pharma AS's Sales Annually?
ASND Revenues are $288.8M -
How Much Profit Does Ascendis Pharma AS's Make A Year?
ASND net income is -$521.2M
Is Ascendis Pharma AS Growing As A Company?
-
What Is Ascendis Pharma AS's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.25% -
What Is Ascendis Pharma AS's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Ascendis Pharma AS Stock Price Performance
-
Did Ascendis Pharma AS Stock Go Up Last Month?
Ascendis Pharma AS share price went down by -0.62% last month -
Did ASND's Share Price Rise Over The Last Year?
ASND share price rose by 36.08% over the past 1 year
What Is Ascendis Pharma AS 52-Week High & Low?
-
What Is Ascendis Pharma AS’s 52-Week High Share Price?
Ascendis Pharma AS has traded as high as $161.00 over the past 52 weeks -
What Is Ascendis Pharma AS’s 52-Week Low Share Price?
Ascendis Pharma AS has traded as low as $90.13 over the past 52 weeks
Ascendis Pharma AS Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Ascendis Pharma AS?
-
How Much Debt Does Ascendis Pharma AS Have?
Total long term debt quarterly is $721M -
How Much Cash Does Ascendis Pharma AS Have?
Cash and short term investments quarterly total is $277.3M -
What Is Ascendis Pharma AS’s Book Value Per Share?
Book value per share is -6.00
Is Ascendis Pharma AS Cash Flow Positive?
Data Unavailable
Ascendis Pharma AS Return On Invested Capital
-
Is Management Doing A Good Job?
ASND return on invested capital is -109.54% -
What Is Ascendis Pharma AS Return On Assets?
ROA measures how assets are converting to revenues and is -60.1% -
What Is ASND Return On Equity?
ROE is a measure of profitability and is 0%
Ascendis Pharma AS Earnings Date & Stock Price
-
What Is Ascendis Pharma AS's Stock Price Today?
A single share of ASND can be purchased today for 126.51 -
What Is Ascendis Pharma AS’s Stock Symbol?
Ascendis Pharma AS trades on the nasdaq under the ticker symbol: ASND -
When Is Ascendis Pharma AS’s Next Earnings Date?
The next quarterly earnings date for Ascendis Pharma AS is scheduled on February 7, 2025 -
When Is ASND's next ex-dividend date?
Ascendis Pharma AS's next ex-dividend date is November 18, 2024 -
How To Buy Ascendis Pharma AS Stock?
You can buy Ascendis Pharma AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Ascendis Pharma AS Competitors
-
Who Are Ascendis Pharma AS's Competitors?
Below is a list of companies who compete with Ascendis Pharma AS or are related in some way:
Ascendis Pharma AS Dividend Yield
-
What Is ASND Dividend Yield?
Ascendis Pharma AS’s dividend yield currently is 0% -
What Is Ascendis Pharma AS’s Payout Ratio?
Ascendis Pharma AS’s payout ratio is 0% -
When Did Ascendis Pharma AS Last Pay A Dividend?
The latest dividend pay date is November 18, 2024 -
What Is Ascendis Pharma AS’s Dividend Per Share?
Ascendis Pharma AS pays a dividend of $0.00 per share
Ascendis Pharma AS Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -14.28% |
| Revenue: | -25% | -14.91% |
Analyst Recommendations
| Buy Recommendations: | 11 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 189.24 |
| Upside from Last Price: | 49.58% |